Technology News and Research

RSS

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.

16 May 2018

Researchers identify technology to prevent false positives in CT-based lung cancer screening

A team of researchers including investigators from Mayo Clinic has identified a technology to address the problem of false positives in CT-based lung cancer screening. The team's findings are published in the current issue of PLOS One.

16 May 2018

KTU researchers are developing mathematical methods to diagnose breast cancer

The team of researchers at Kaunas University of Technology, Lithuania are developing mathematical methods which could help diagnose breast cancer.

15 May 2018

Infiniti Research completes new market entry advisory study on wound management industry

Infiniti Research, a global market and customer intelligence solutions provider, has announced the completion of their new market entry advisory study on the wound management industry.

15 May 2018

Nightingale Health adds urine, CSF and cord blood analysis to its blood biomarker services

Nightingale Health, the Finnish innovator of an internationally recognized blood biomarker testing technology, today announced further steps towards widespread expansion and development of its services.

15 May 2018

Research Ready program launched for physician practices interested in becoming a study site

Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, has launched a Research Ready program for physician practices interested in becoming a study site.

15 May 2018

Lash Group introduces latest solution for electronic benefit verification

Lash Group, a patient support services company and an AmerisourceBergen company, today announced the launch of its newest solution for electronic benefit verification (eBV).

15 May 2018

Scientists find overlap between causes of RA and Huntington’s disease

Using new analytic tools, researchers at University of California San Diego School of Medicine and the Icahn School of Medicine at Mount Sinai have decoded the epigenetic landscape for rheumatoid arthritis (RA), a common autoimmune disease that affects more than 1.3 million Americans.

15 May 2018

Nuffield Council on Bioethics outlines ethical issues arising from use of AI in healthcare

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide.

15 May 2018

Will we still be relevant ‘when we're 64’?

A gnawing sense of irrelevancy and invisibility suddenly hits many aging adults, as their life roles shift from hands-on parent to empty nester or from workaholic to retiree. Self-worth and identity may suffer as that feeling that you matter starts to fade.

15 May 2018

Study shows consumer sleep technology needs further validation

According to a position statement from the American Academy of Sleep Medicine, consumer sleep technology must be cleared by the Food and Drug Administration and rigorously tested if it is intended to diagnose or treat sleep disorders.

15 May 2018

Researchers to take 'unprecedented look' into protein behind hypertension, epilepsy, and overactive bladder

The seemingly unrelated conditions of hypertension, epilepsy and overactive bladder may be linked by electrical activity in a protein long studied by a biomedical engineer at Washington University in St. Louis.

15 May 2018

Invasive cancers that are born to be bad show detectable differences from harmless tumors

Do metastatic cancer tumors "break bad" or are they "born bad"? This question is an essential mystery in cancer early detection and treatment. Lacking a clear answer, patients are given the same aggressive therapies when small, abnormal clusters of cells are discovered early, even though they might well be harmless.

15 May 2018

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Multiple myeloma is the second most common type of blood cancer in the United States, impacting more than 25,000 people each year and disproportionatly affecting African-American men.

15 May 2018

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

Children who underwent cardiac surgery were less likely to develop acute kidney injury if they had been treated with acetaminophen in the first 48 hours after their procedures, according to a Vanderbilt study just published in JAMA Pediatrics.

15 May 2018

UTA bioengineering professor successfully patents new cancer trap

The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.

14 May 2018

Scientists design new computational strategy to enable more personalized cancer treatment

Mathematicians and cancer scientists have found a way to simplify complex biomolecular data about tumors, in principle making it easier to prescribe the appropriate treatment for a specific patient.

14 May 2018

Protein researchers identify several new potential targets for cancer

In a new study based on mouse cells internationally leading protein researchers have identified several new potential targets using state-of-the-art technology, many of which could be employed for future treatment of different types of cancers and diseases.

14 May 2018

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.

14 May 2018

LogicBio team to present data on preclinical effectiveness of GeneRide platform

LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe medicines with lasting therapeutic benefit for children with life-threatening diseases, today announced it will be presenting data on the company's technology and robust preclinical pipeline at the annual meeting of the American Society of Gene & Cell Therapy at the Hilton Chicago, from May 16-19, 2018.

14 May 2018

Technology News and Research

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Researchers identify technology to prevent false positives in CT-based lung cancer screening

KTU researchers are developing mathematical methods to diagnose breast cancer

Infiniti Research completes new market entry advisory study on wound management industry

Nightingale Health adds urine, CSF and cord blood analysis to its blood biomarker services

Research Ready program launched for physician practices interested in becoming a study site

Lash Group introduces latest solution for electronic benefit verification

Scientists find overlap between causes of RA and Huntington’s disease

Nuffield Council on Bioethics outlines ethical issues arising from use of AI in healthcare

Will we still be relevant ‘when we're 64’?

Study shows consumer sleep technology needs further validation

Researchers to take 'unprecedented look' into protein behind hypertension, epilepsy, and overactive bladder

Invasive cancers that are born to be bad show detectable differences from harmless tumors

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

UTA bioengineering professor successfully patents new cancer trap

Scientists design new computational strategy to enable more personalized cancer treatment

Protein researchers identify several new potential targets for cancer

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

LogicBio team to present data on preclinical effectiveness of GeneRide platform

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News